Markus Sieger

CIK 1337143 · last filed 2026-01-30

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$562.5K

Companies

4

Total Filings

47

Lifetime Open-Market Net

$329.8K

Filer Profile

Reported Address
BEUTSTWEG 12
CH-8032
ZURICH, V8 000000000
Related Filers
Rafael Holdings, Inc. — 3 joint filings, latest 2026-01-30
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
RFL Director 219,710 $2.56 $562.5K $0 1 2026-01-30
Rafael Holdings, Inc. (RFL.WS) Delisted Director 190,182 $0.01 $2.7K $0 1 2025-05-29
Cyclo Therapeutics, Inc. (CYTHW) Delisted Director 440,260 $0.03 $14.1K $214.4K 23 2025-03-03
CENTRAL EUROPEAN DISTRIBUTION CORP (CEDC) Delisted Director 17,500 $115.4K 8 2011-08-22

Recent Filings · Page 2 of 5

47 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2023-05-18 Cyclo Therapeutics, Inc. (CYTHW) Delisted Grant (A) +42,962 $0 EDGAR
2023-04-24 Cyclo Therapeutics, Inc. (CYTHW) Delisted Buy (P) +59,881 $42.5K EDGAR
2023-03-09 Cyclo Therapeutics, Inc. (CYTHW) Delisted Grant (A) $0 EDGAR
2022-11-09 Cyclo Therapeutics, Inc. (CYTHW) Delisted Grant (A) +9,496 $0 EDGAR
2022-08-04 Cyclo Therapeutics, Inc. (CYTHW) Delisted Grant (A) +5,762 $0 EDGAR
2022-05-04 Cyclo Therapeutics, Inc. (CYTHW) Delisted Grant (A) +4,223 $0 EDGAR
2022-03-30 Cyclo Therapeutics, Inc. (CYTHW) Delisted Buy (P) +10,000 $27.3K EDGAR
2022-02-01 Cyclo Therapeutics, Inc. (CYTHW) Delisted Grant (A) +4,075 $0 EDGAR
2021-08-30 Cyclo Therapeutics, Inc. (CYTHW) Delisted Grant (A) $0 EDGAR
2021-06-21 Cyclo Therapeutics, Inc. (CYTHW) Delisted Buy (P) $0 EDGAR
Showing 1120 of 47
Page 2 of 5
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.